Loomis, Sayles & Company’s HealthStream HSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-957
Closed -$27K 649
2019
Q1
$27K Sell
957
-13
-1% -$342 ﹤0.01% 575
2018
Q4
$23K Sell
970
-153
-14% -$3.97K ﹤0.01% 662
2018
Q3
$35K Buy
1,123
+245
+28% +$7.33K ﹤0.01% 631
2018
Q2
$24K Hold
878
﹤0.01% 753
2018
Q1
$22K Buy
+878
New +$21.1K ﹤0.01% 766
2017
Q1
Sell
-199,905
Closed -$5.01M 991
2016
Q4
$5.01M Sell
199,905
-3,413
-2% -$87.9K 0.01% 535
2016
Q3
$5.61M Sell
203,318
-2,596
-1% -$67.1K 0.01% 506
2016
Q2
$5.46M Buy
205,914
+127,646
+163% +$3M 0.01% 503
2016
Q1
$1.73M Buy
78,268
+291
+0.4% +$5.99K ﹤0.01% 548
2015
Q4
$1.72M Buy
77,977
+44,727
+135% +$1.04M ﹤0.01% 562
2015
Q3
$725K Buy
33,250
+4,440
+15% +$118K ﹤0.01% 585
2015
Q2
$876K Buy
28,810
+3,199
+12% +$91.6K ﹤0.01% 578
2015
Q1
$645K Buy
25,611
+23,206
+965% +$632K ﹤0.01% 626
2014
Q4
$71K Buy
+2,405
New +$68.3K ﹤0.01% 692

Other funds holding HSTM

Loomis, Sayles & Company's HSTM Position: Q2 2019 in Review

Loomis, Sayles & Company sold out of HealthStream (HSTM) in Q2 2019, closing a stake of 957 shares — an estimated $27K sold.

Loomis, Sayles & Company first reported a position in HSTM in Q4 2014 and held it in 14 quarters. The position peaked at $5.61M in Q3 2016. 147 funds tracked by Wall St. Rank hold HSTM as of Q2 2019.

  • Loomis, Sayles & Company reported no remaining HealthStream position as of Q2 2019 after selling out during the quarter.
  • Loomis, Sayles & Company sold 957 HealthStream shares in Q2 2019, an estimated $27K.
  • Loomis, Sayles & Company first reported a position in HealthStream in Q4 2014 and held it in 14 quarters.
  • Loomis, Sayles & Company's HealthStream position peaked at $5.61M in Q3 2016.
  • 147 funds tracked by Wall St. Rank held HealthStream as of Q2 2019.

Based on Loomis, Sayles & Company's 13F filing for Q2 2019, filed 14 Aug 2019.